Joseph Vazzano
2020 - AVENUE THERAPEUTICS
In 2020, Joseph Vazzano earned a total compensation of $214.9K as Chief Financial Officer at AVENUE THERAPEUTICS, a 17% decrease compared to previous year.
Compensation breakdown
| Salary | $206,000 |
|---|---|
| Other | $8,890 |
| Total | $214,890 |
Vazzano received $206K in salary, accounting for 96% of the total pay in 2020.
Vazzano also received $8.9K in other compensation.
Rankings
In 2020, Joseph Vazzano's compensation ranked 12,529th out of 13,090 executives tracked by ExecPay. In other words, Vazzano earned more than 4.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,529 out of 13,090 | 4th |
Division Manufacturing | 5,378 out of 5,620 | 4th |
Major group Chemicals And Allied Products | 2,175 out of 2,253 | 4th |
Industry group Drugs | 1,890 out of 1,953 | 3rd |
Industry Pharmaceutical Preparations | 1,409 out of 1,458 | 3rd |
Source: SEC filing on November 23, 2021.
Vazzano's colleagues
We found one more compensation record of an executive who worked with Joseph Vazzano at AVENUE THERAPEUTICS in 2020.
2020
Lucy Lu
AVENUE THERAPEUTICS
Chief Executive Officer
News
Abeona Therapeutics CEO Vishwas Seshadri's 2023 pay jumps 90% to $2.8M
March 19, 2024
Abeona Therapeutics CEO Vishwas Seshadri's 2022 pay slips 4% to $1.5M
April 13, 2023
AVENUE THERAPEUTICS CEO Lucy Lu's 2021 pay jumps 144% to $1.1M
November 18, 2022
AVENUE THERAPEUTICS CEO Lucy Lu's 2020 pay falls 31% to $443K
November 23, 2021
AVENUE THERAPEUTICS CEO Lucy Lu's 2019 pay falls 60% to $640K
April 29, 2020
AVENUE THERAPEUTICS CEO Lucy Lu's 2018 pay falls 22% to $1.6M
April 30, 2019